Early vasodilator response to anodal current application in human is not impaired by cyclooxygenase-2 blockade

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 4 57-4, 2005, Pages

  Tartas, Maylis ^a   Bouyé, Philippe ^a   Koïtka, Audrey ^b   Durand, Sylvain ^a   Gallois, Yves ^a   Saumet, Jean Louis ^b   Abraham, Pierre ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b University of Medicine   (France)

Author keywords

Neurogenic inflammation; Neuropeptide release; Skin blood flow

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; PROSTACYCLIN;

ADULT; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; LASER DOPPLER FLOWMETRY; NEUROGENIC INFLAMMATION; NEUROTRANSMITTER RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; VASODILATATION;

ADULT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ELECTRIC STIMULATION; ELECTRODES; HUMANS; INDOMETHACIN; IONTOPHORESIS; LASER-DOPPLER FLOWMETRY; MALE; MEMBRANE PROTEINS; MICROCIRCULATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SKIN; SULFONAMIDES; VASODILATION;

EID: 15744365248     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00415.2004     Document Type: Article

References (46)

1. Abou-Elenin K, Xydakis A, Hamdy O, Economides PA, Horton ES, and Veves A. The effect of aspirin and various iontophoresis solution vehicles on skin microvascular reactivity. Microvasc Rex 63: 91-95, 2002.
2. Adelizzi RA. COX-1 and COX-2 in health and disease. J Am Osteopath Assoc 99: S7-S12, 1999.
3. Berliner MN. Skin microcirculation during tap water iontophoresis in humans: cathode stimulates more than anode. Microvasc Res 54: 74-80, 1997.
4. Bishop-Bailey D, Pepper JR, Larkin SW, and Mitchell JA. Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: role of endogenous prostanoids. Arterioscler Thromb Vasc Biol 18: 1655-1661, 1998.
5. Cannon GW and Breedveld FC. Efficacy of cyclooxygenase-2-specific inhibitors. Am J Med 110 Suppl 3A: 6S-12S, 2001.
6. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 24 Suppl 49: 15-19, 1997.
7. Durand S, Fromy B, Bouye P, Saumet JL, and Abraham P. Current-induced vasodilation during water iontophoresis (5 min, 0.10 mA) is delayed from current onset and involves aspirin-sensitive mechanisms. J Vasc Res 39: 59-71, 2002.
8. Durand S, Fromy B, Bouye P, Saumet JL, and Abraham P. Vasodilatation in response to repeated anodal current application in the human skin relies on aspirin-sensitive mechanisms. J Physiol 540: 261-269, 2002.
9. Durand S, Fromy B, Humeau A, Sigaudo-Roussel D, Saumet JL, and Abraham P. Break excitation alone does not explain the delay and amplitude of anodal current-induced vasodilatation in human skin. J Physiol 542: 549-557, 2002.
10. 2 following oral administration of various dosage forms of indomethacin [in German]. Z Rheumatol 42: 235-241, 1983.
11. FitzGerald GA and Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345: 433-442, 2001.
12. FitzGerald GA, Pedersen AK, and Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 67: 1174-1177, 1983.
13. Freed MI, Audet PR, Zariffa N, Krishna GG, Ilson BE, Everitt DE, Brown LE, Rizzo SM, Nichols AI, and Jorkasky DK. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers. J Clin Pharmacol 34: 1098-1108, 1994.
14. Gardner-Medwin JM, Taylor JY, Macdonald IA, and Powell RJ. An investigation into variability in microvascular skin blood flow and the responses to transdermal delivery of acetylcholine at different sites in the forearm and hand. Br J Clin Pharmacol 43: 391-397, 1997.
15. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, and Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care 24: 344-349, 2001.
16. Herbert MK, and Holzer PI. Neurogenic inflammation. Basic mechanisms, physiology and pharmacology [in German]. Anasthesiol Intensivmed Notfallmed Schmerzther 37: 314-325, 2002.
17. Hutchins B, Patel H, and Spears R. Attenuation of pro-inflammatory neuropeptide levels produced by a cyclooxygenase-2 inhibitor in an animal model of chronic temporomandibular joint inflammation. J Orofac Pain 16: 312-316, 2002.
18. Johnson J. The cutaneous circulation. In: Laser Doppler Blood Flowmetry, edited by Oberg P. Boston, MA: Kluwer Academic, 1990, p. 121-140.
19. Johnson JM, O'Leary DS, Taylor WF, and Kosiba W. Effect of local warming on forearm reactive hyperaemia. Clin Physiol 6: 337-346, 1986.
20. Kellogg DL Jr, Crandall CG, Liu Y, Charkoudian N, and Johnson JM. Nitric oxide and cutaneous active vasodilation during heat stress in humans. J Appl Physiol 85: 824-829, 1998.
21. Khan F, Davidson NC, Littleford RC, Litchfield SJ, Struthers AD, and Belch JJ. Cutaneous vascular responses to acetylcholine are mediated by a prostanoid-dependent mechanism in man. Vasc Med 2: 82-86, 1997.
22. Kvandal P, Stefanovska A, Veber M, Desiree Kvermmo H, and Arvid Kirkeboen K. Regulation of human cutaneous circulation evaluated by laser-Doppler flowmetry, iontophoresis, and spectral analysis: importance of nitric oxide and prostaglandins. Microvasc Res 65: 160-171, 2003.
23. Magerl W and Treede RD. Heat-evoked vasodilatation in human hairy skin: axon reflexes due to low-level activity of nociceptive afferents. J Physiol 497: 837-848, 1996.
24. Martinez RV, Reval M, Campos MD, Terron JA, Dominguez R, and Lopez-Munoz FJ. Involvement of peripheral cyclooxygenase-1 and cyclooxygenase-2 in inflammatory pain. J Pharm Pharmacol 54: 405-412, 2002.
25. Mazario J, Gaitan G, and Herrero JF. Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Neuropharmacology 40: 937-946, 2001.
26. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, and FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 96: 272-277, 1999.
27. Morris SJ and Shore AC. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 496: 531-542, 1996.
28. Noon JP, Walker BR, Hand MF, and Webb DJ. Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids, rather than nitric oxide. Br J Clin Pharmacol 45: 545-550, 1998.
29. Peters JK, Nishiyasu T, and Mack GW. Reflex control of the cutaneous circulation during passive body core heating in humans. J Appl Physiol 88: 1756-1764, 2000.
30. Rane A, Oelz O, Frolich JC, Seyberth HW, Sweetman BJ, Watson JT, Wilkinson GR, and Oates JA. Relation between plasma concentration, of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther 23: 658-668, 1978.
31. Richardson JD and Vasko MR. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 302: 839-845, 2002.
32. Sattar N, Petrie JR, and Jaap AJ. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis 138: 229-235, 1998.
33. Saumet JL, Abraham P, and Jardel A. Cutaneous vasodilation induced by local warming, sodium nitroprusside, and bretylium iontophoresis on the hand. Microvasc Res 56: 212-217, 1998.
34. Saumet JL, Dittmar A, and Leftheriotis G. Non-invasive measurement of skin blood flow: comparison between plethysmography, laser-Doppler flowmeter and heat thermal clearance method. Int J Microcirc Clin Exp 5: 73-83, 1986.
35. Saumet JL, Kellogg DL Jr, Taylor WF, and Johnson JM. Cutaneous laser-Doppler flowmetry: influence of underlying muscle blood flow. J Appl Physiol 65: 478-481, 1988.
36. Savage MV and Brengelmann GL. Reproducibility of the vascular response to heating in human skin. J Appl Physiol 76: 1759-1763, 1994.
37. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Masferrer JL, Seibert K, and Isakson PC. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95: 13313-13318, 1998.
38. Szallasi A and Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159-212, 1999.
39. Szolcsanyi J. Neurogenic inflammation: reevaluation of axon reflex theory. In: Neurogenic Inflammation, edited by Gepetti P and Holzer P. Boca Raton, FL: CRC, 1996, p. 33-42.
40. Taylor WF, Johnson JM, O'Leary D, and Park MK. Effect of high local temperature on reflex cutaneous vasodilation. J Appl Physiol 57: 191-196, 1984.
41. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232-235, 1971.
42. Vane JR, Bakhle YS, and Bolting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998.
43. Vanegas H and Schaible HG. Prostaglandins and Cyclooxygenases [correction of cycloxygenases] in the spinal cord. Prog Neurobiol 64: 327-363, 2001.
44. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, and Freeman R. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47: 457-463, 1998.
45. Voilley N, de Weille J, Mamet J, and Lazdunski M. Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci 21: 8026-8033, 2001.
46. Zauli G, Pandolfi A, Gonelli A, Di Pietro R, Guarnieri S, Ciabattoni G, Rana R, Vitale M, and Secchiero P. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. Circ Res 92: 732-740, 2003.